menu
    • menu

    Company profile for NewcelX

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NewcelX Ltd. is a clinical-stage biotechnology company focused on developing innovative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. Leveraging advanced stem-cell technologies and neuroscience expertise, the company aims to deliver scalable regenerative treatments for conditions such as ALS and Type 1 diabetes. Headquartered in Zurich, Switzerland, NewcelX is committed to advancing tran...
    NewcelX Ltd. is a clinical-stage biotechnology company focused on developing innovative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. Leveraging advanced stem-cell technologies and neuroscience expertise, the company aims to deliver scalable regenerative treatments for conditions such as ALS and Type 1 diabetes. Headquartered in Zurich, Switzerland, NewcelX is committed to advancing transformative therapies that improve patient outcomes worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NewcelXSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    The Circle 6, P.O. Box, CH - 8058 Zurich
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://newcelx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NewcelX advances T1D therapy with Eledon Pharmaceuticals
    NewcelX advances T1D therapy with Eledon Pharmaceuticals

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284829/0/en/newcelx-reports-financial-results-for-2025-and-provides-shareholders-with-update-on-accelerated-development-of-type-1-diabetes-treatment-in-collaboration-with-eledon-pharmaceutical.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    NewcelX Prices $1.35M Equity Financing at 30% Premium
    NewcelX Prices $1.35M Equity Financing at 30% Premium

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266497/0/en/NewcelX-Announces-Pricing-of-1-35-Million-Equity-Financing-at-30-Premium-Pricing.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    NewcelX, Eledon Pharma Partner on NCEL-101 for Type 1 Diabetes
    NewcelX, Eledon Pharma Partner on NCEL-101 for Type 1 Diabetes

    09 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/newcelx-announces-strategic-collaboration-with-eledon-pharmaceuticals-to-advance-ncel-101-program-for-type-1-diabetes-302708071.html

    PR NEWSWIRE
    09 Mar 2026
    Share Share
    NewcelX Advances CVR via Peer-Reviewed Mazindol IR/SR Data
    NewcelX Advances CVR via Peer-Reviewed Mazindol IR/SR Data

    12 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/newcelx-reports-peer-reviewed-publication-supporting-mazindol-irsr-and-advances-cvr-monetization-strategy-302686180.html

    PR NEWSWIRE
    12 Feb 2026
    Share Share
    NewcelX Appoints Swiss Big Pharma Leader Dr. Julien Boisdron
    NewcelX Appoints Swiss Big Pharma Leader Dr. Julien Boisdron

    05 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/newcelx-appoints-dr-julien-boisdron-a-swiss-big-pharma-leader-in-diabetes-innovation-to-its-scientific-advisory-board-302652531.html

    PR NEWSWIRE
    05 Jan 2026
    Share Share
    NewcelX Broadens IP Reach With DOXA Patent Application In China
    NewcelX Broadens IP Reach With DOXA Patent Application In China

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/newcelx-expands-intellectual-property-footprint-with-publication-of-doxa-patent-application-in-china-302638937.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search